Arc
Commercial- Indications
- Depression
Company intelligence / Profile preview
Mave Health has launched Arc, a non-invasive brain stimulation wearable device for at-home treatment of depression and anxiety. The device uses tDCS technology and is integrated into a 12-week program that includes therapy, nutrition advice, fitness coaching, psychiatric oversight, and personalized support. Over 10,000 users have completed more than 3 million sessions with an 88% self-reported improvement rate and no reported side effects. Clinical efficacy is supported by collaborations with leading academic institutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mave Health.